City

Boston (2)

Condition

Anaplastic Lymphoma Kinase Gene Translocation (2)

Lung Cancer (1)

MET Amplification (1)

NSCLC (1)

Non-Small Cell Lung Cancer (1)

ROS1 Rearrangement (1)

Relapsed Cancer (1)

Resistant Cancer (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Massachusetts General Hospital (2)

Collaborator

Addario Lung Cancer Medical Institute (1)

Array BioPharma (1)

Lungevity Foundation (1)

Pfizer (1)

Intervention

binimetinib (1)

crizotinib (1)

lorlatinib (1)

tno155 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

anaplastic lymphoma kinase gene translocation

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Anaplastic Lymphoma Kinase Gene Translocation, NSCLC Trial in Boston

Recruiting

Anaplastic Lymphoma Kinase Gene Translocation
Non-Small Cell Lung Cancer

Boston, Massachusetts

Massachusetts General Hospital Cancer Center

Jan 14, 2022

Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation, ROS1 Rearrangement Trial in Boston (Lorlatinib, Crizotinib,

Recruiting

Lung Cancer
+6 more

Lorlatinib
+3 more

Boston, Massachusetts
+1 more

Mar 7, 2021